Commitment COM-002
Post-approval commitment for EMA-2023-0002. Category: Paediatric Study. Priority: high.
Commitment ID
COM-002
Application
Authority
European Medicines Agency
Category
Paediatric Study
Priority
high
Status
Overdue
Due Date
2024-12-18
Completed At
—
Owner
Carlos Mendez
Created
2022-06-11
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.